Lapsley M, Sansom P A, Marlow C T, Flynn F V, Norden A G
Department of Chemical Pathology, University College and Middlesex School of Medicine, London.
J Clin Pathol. 1991 Oct;44(10):812-6. doi: 10.1136/jcp.44.10.812.
Urinary beta 2-glycoprotein-1 was measured in 60 patients with conditions recognised as causing renal tubular impairment and compared with established markers of early tubular malfunction. Increased beta 2-glycoprotein-1 excretion was found in 49 (82%) of the subjects; raised excretion of alpha 1-microglobulin, retinol-binding protein, and beta 2-microglobulin was found in 46 (77%), 45 (75%), and 31 (52%), respectively, and increased urinary N-acetyl-beta-D-glucosaminidase activity in 32 of 54 of the subjects (59%). The increase was particularly pronounced in those with proximal tubule malfunction, although considerable variation occurred. beta 2-glycoprotein-1 was shown to be stable in urine over the physiological pH range, and it is concluded that its measurement provides a means of detecting chronic malfunction of the renal tubules that is marginally more sensitive than assays of alpha 1-microglobulin or retinol-binding protein, and more reliable than assays of beta 2-microglobulin or N-acetyl-beta-D-glucosaminidase.
对60例被认为可导致肾小管损伤的患者测定了尿β2-糖蛋白-1,并与早期肾小管功能障碍的既定标志物进行了比较。49例(82%)受试者的β2-糖蛋白-1排泄增加;α1-微球蛋白、视黄醇结合蛋白和β2-微球蛋白排泄增加的分别有46例(77%)、45例(75%)和31例(52%),54例受试者中有32例(59%)尿N-乙酰-β-D-氨基葡萄糖苷酶活性增加。尽管存在相当大的差异,但在近端肾小管功能障碍患者中增加尤为明显。结果表明,β2-糖蛋白-1在生理pH范围内的尿液中稳定,得出的结论是,其测定提供了一种检测肾小管慢性功能障碍的方法,该方法比α1-微球蛋白或视黄醇结合蛋白检测略敏感,比β2-微球蛋白或N-乙酰-β-D-氨基葡萄糖苷酶检测更可靠。